EAVE II logo


Our Publications

See our findings in academic paper publications.

Quick Access List

A reference list of our key academic paper publications

Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study

January 2022: Research published in The Lancet Respiratory Medicine looks at which adults with asthma in Scotland might be at risk of serious complications from COVID-19.

SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland

January 2022: Research published in Nature Medicine looks at COVID-19 disease and vaccination in pregnant women in Scotland, and the impact this has had on their health.

Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time

December 2021: The protection offered by the Oxford-Astra Zeneca Covid-19 vaccine declines after three months of receiving two doses, a study says.

Risk of COVID-19 hospital admission among children aged 5–17 years with asthma in Scotland: a national incident cohort study

November 2021: Research published in The Lancet Respiratory Medicine looks at the risk of children with asthma in Scotland being admitted to hospital with COVID-19.

Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland

October 2021: A research letter published in The Lancet looks at people in Scotland who have died of COVID-19 after two vaccine doses, and what the risks and causes might be.

Neurological complications after first dose of COVID-19 vaccination and SARS-CoV-2 infection

October 2021: Vaccine data analysis from England and Scotland, published in the Nature Medicine, looks at possible links between conditions of the nervous system and COVID-19 infection and vaccination.

Association between multimorbidity and mortality in a cohort of patients admitted to hospital with COVID-19 in Scotland

October 2021: Research published in the Journal of the Royal Society of Medicine looks at the risk of death after being admitted to hospital with COVID-19. We look at patients who were shielding or living with multiple long term conditions, during the first wave of the pandemic in Scotland.

Vaccine Efficacy against the Delta Variant in Scotland

October 2021: Research published in the New England Journal of Medicine estimates the level of protection that vaccines give against deaths from COVID-19 infection with the Delta variant.

COVID-19 hospital admissions and deaths post BNT162b2 and ChAdOx1 vaccinations: National prospective cohort study of 2.57 million people in Scotland

September 2021: New research published in The Lancet Respiratory Medicine looks at the number of people in Scotland who have died from or been admitted to hospital with COVID-19 after at least one vaccine dose.

Predicted COVID-19 positive cases, hospitalisations, and deaths associated with the Delta variant of concern, June–July, 2021 (EURO 2020)

July 2021: A research letter in The Lancet Digital Health models the impact of the Delta variant on COVID-19 cases, hospital admissions and deaths in Scotland around the time of EURO 2020.

Temporal trends and forecasting of COVID-19 hospitalisations and deaths in Scotland using a national real-time patient-level data platform: a statistical modelling study

July 2021: A paper published in The Lancet Digital Health describes the EAVE II platform and its use to monitor and forecast COVID-19 health outcomes across the Scottish population since March 2020.

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness

The Delta variant of COVID-19 is associated with approximately double the risk of hospitalisation compared with the Alpha variant, but vaccine continues to protect.

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.

EAVE II study of 2.53 million first COVID-19 vaccine doses across Scotland shows small increases in risk for some adverse events following Oxford-AstraZeneca vaccine.

Cohort profile: Early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II) database

The EAVE II cohort profile, detailing why the cohort was set up, who is in the cohort, and what has been found, measured, and more.

Impact of COVID-19 Lockdown on the Incidence and Mortality of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: National Interrupted Time Series Analyses for Scotland and Wales

First national level analysis shows hospital admissions for COPD (Chronic Obstructive Pulmonary Disease) across Scotland and Wales fell during the first COVID-19 lockdown.

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland

A milestone study, which points to the success of first dose mass vaccination in reducing COVID-19 hospitalisations across Scotland, is now available from The Lancet.

Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales

Study finds 36% fewer people were admitted to hospital in Scotland and Wales in the first lockdown due to asthma.

Pre-print of COVID-19 Vaccines Effectiveness in Scotland paper

Vaccination has been linked to a substantial reduction in the risk of Covid-19 admissions to Scotland’s hospitals, landmark research suggests in pre-print.

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from COVID-19 in adults: national derivation and validation cohort study

A study to derive and validate a risk prediction algorithm to estimate hospital admission and mortality outcomes from COVID-19 in adults.

Impact of COVID-19 on accident and emergency attendances and admissions in Scotland

New study highlights disruptive impact of pandemic on non-COVID NHS care in Scotland

EAVE II Study Protocol

Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): Protocol for an Observational Study using Linked Scottish National Data